Skip to main content

NSF Pharma Biotech Conference 2026

Join NSF in London for the fourth annual Pharma Biotech Conference as the industry explores how to move from compliance to resilience and build quality systems that withstand disruption.

Date: Thursday 19th November 2026
Venue: The Royal Society of Chemistry, Burlington House, Piccadilly, London, United Kingdom

About the Conference

NSF is pleased to announce its 4th annual Pharma Biotech Conference, taking place on 19 November 2026 at the Royal Society of Chemistry in London. Building on the success of the 2023, 2024 and 2025 events, this year's conference returns with its most ambitious and forward-looking program yet and forms part of the inaugural NSF Summit Series.

This year's theme is "From Compliance to Resilience: How Companies Can Build Quality Systems That Withstand Disruption." Pharma and biotech organizations are operating in an environment shaped by geopolitical uncertainty, changing global trade dynamics, supply chain pressure, digital disruption, workforce challenges and increasing scrutiny around product quality and patient safety. The conference will explore how leaders can move beyond compliance and build quality systems, leadership approaches and operating models that remain effective under pressure.

What to expect

The conference will combine expert presentations, practical case studies, panel discussion and networking time designed for meaningful peer exchange. You will hear perspectives from NSF subject matter experts as well as invited industry speakers from global pharmaceutical companies, biotechnology organizations, CDMOs and regulatory bodies working at the sharp end of quality, validation, manufacturing and regulatory decision-making.

Why attend

Delegates will leave with practical, experience-led insight on strengthening quality systems, responding to regulatory uncertainty, learning from peer experience and preparing their teams for what comes next.

Who should attend

  • Quality assurance and quality systems leaders
  • Regulatory affairs professionals
  • Validation and qualification specialists
  • Manufacturing and operations leaders
  • Compliance and auditing professionals
  • Technical, clinical and supply chain decision-makers within pharma and biotech

Conference Agenda

TimeHeadlineSpeaker / Abstract
09:00Registration & NetworkingStart the day with coffee, conversation and an opportunity to connect with fellow pharmaceutical and biotechnology professionals.
09:50Welcome Address

Magdalena Müller, Director, Life Sciences EMEA, NSF

Magdalena Müller will welcome attendees, introduce the conference theme and set the context for a day focused on quality, resilience, leadership and sustainable growth.

10:00Navigating Uncertainty: The Regulatory and Market Forces Reshaping Pharmaceutical Quality

Dr. Peter Gough, NSF

Pharmaceutical organizations must respond to changing regulatory expectations, supply chain pressures and accelerating innovation without losing control of quality or compliance. Dr. Peter Gough will examine the forces influencing the sector and highlight the issues quality leaders should be preparing for now.


 

What you’ll learn:

  • Which regulatory and industry developments could affect quality strategies
  • How emerging risks may influence compliance and operational priorities
  • Where quality leaders should focus to prepare their organizations for change
10:25Resilient Quality Leadership: Sustaining Performance Through Change

Breda Quinn, Reckitt

Quality leaders must maintain compliance and organizational alignment while supporting growth and navigating constant change. Drawing on senior leadership experience in regulated organizations, Breda Quinn will share practical approaches to keeping quality influential and effective during transformation.


 

You’ll gain practical insight into:

  • Strengthening quality culture when priorities and resources are under pressure
  • Improving cross-functional alignment and leadership engagement
  • Positioning quality as an enabler of performance, change and growth
10:50Policy, Trade and the Global Landscape: What Quality Leaders Need to Prepare For

Raul Radoi, NSF

Policy changes, international trade pressures and supply chain complexity can create new risks across pharmaceutical operations. Raul Radoi will explore how developments in the wider global landscape may affect quality strategy, compliance planning and organizational resilience.


 

Key insights:

  • How policy and trade developments can translate into operational quality risks
  • Which external pressures may affect supply continuity and compliance
  • How to build greater awareness of global change into business planning
11:20Networking Refreshment BreakRefresh, reconnect and continue the morning’s conversations with speakers and fellow attendees.
11:50Building Quality Into Growth: Lessons From Scaling a Cell and Gene Therapy Operation

Emma Ewins, Exmoor Pharma

Scaling advanced therapy operations can expose weaknesses in quality systems, governance and organizational capability. Drawing on her experience developing and leading a Cell and Gene Therapy manufacturing operation, Emma Ewins will share how quality can be embedded from the outset rather than added after growth has created gaps.


 

Take away practical approaches for:

  • Designing quality systems that can scale with the organization
  • Developing workforce capability, oversight and process consistency
  • Supporting innovation and growth while maintaining inspection readiness
12:15Lean Thinking for Sustainable Quality Performance

Steve Nicolls, The Lean Orange

Complex and inefficient processes can undermine operational performance and quality outcomes. Steve Nicolls will explore how Lean thinking can help organizations simplify work, improve decision-making and create sustainable habits of continuous improvement. Steve Nicolls is listed as TBC in the working agenda.


 

The session will help you:

  • Identify process complexity that adds risk without adding value
  • Apply Lean principles to support stronger quality performance
  • Embed continuous improvement into everyday operations
12:40Moderated Discussion: Turning Resilience Into Reality

Featuring the Morning Speakers

Resilience can remain an abstract ambition unless it is translated into practical decisions, behaviors and operating models. The morning speakers will compare perspectives, examine implementation challenges and discuss what resilient quality leadership looks like in practice.


 

Discussion themes will include:

  • Applying the morning’s ideas within real organizational constraints
  • Overcoming common barriers to quality and operational improvement
  • Connecting leadership, culture and process improvement more effectively
13:00Networking LunchEnjoy lunch while building new connections and continuing discussions with fellow attendees and presenters.
14:00Building Resilient Organizations: Embedding Quality as a Strategic Capability

Catherine Kay, NSF

Many organizations understand the importance of resilience but struggle to turn it into practical improvements in performance and decision-making. Catherine Kay will explore how quality, governance and risk management can work together as strategic capabilities rather than isolated compliance activities.


 

Key takeaways:

  • Recognize the characteristics of a more resilient organization
  • Integrate quality and risk into business decision-making
  • Expand the strategic influence of the quality function
14:25Critical Success Factors for Implementing Strategic Quality Management in Times of Disruption

Nuno Furtado, Amicus Therapeutics

Traditional quality systems may not provide the resilience organizations need during disruption and change. Drawing on Strategic Quality Management research and extensive pharmaceutical and biotechnology experience, Nuno Furtado will examine how quality can move beyond compliance and become a strategic business enabler.


 

You’ll explore how to:

  • Secure the leadership commitment needed for strategic quality management
  • Align governance, quality culture and risk-based decision-making
  • Build quality frameworks that support agility and sustained performance
14:50Networking Refreshment BreakRecharge and reconnect before the final sessions on future quality systems, innovation and growth.
15:20From Compliance to Competitive Advantage: Future-Proofing Quality Systems

Marie O’Callaghan, NSF

Quality systems must do more than demonstrate compliance. They must help organizations identify risk, make better decisions and respond effectively as regulatory and business conditions change. Marie O’Callaghan will explore how quality systems can evolve to deliver greater organizational value.


 

Practical learning points:

  • Move from reactive compliance towards proactive quality management
  • Use risk and data to support stronger operational decisions
  • Position the quality system as a source of business advantage
15:45From Startup to Strategic Partner: Building a Resilient Biotechnology Business

Amy Walker, 4basebio

Biotechnology companies must balance scientific innovation with the operational discipline required to scale, attract investment and meet evolving expectations. Amy Walker will share lessons from the growth of 4basebio and explore how strategic focus, quality and resilience can support long-term progress.


 

Lessons from the case study:

  • Balance innovation with the structures needed for sustainable growth
  • Maintain organizational focus while navigating uncertainty
  • Build resilience into the development of an emerging biotechnology business
16:10Panel Discussion: From Compliance to Resilience

Industry and NSF Expert Panel

The final panel will bring together ideas from across the program and focus on what quality leaders must do next. Panellists will explore how organizations can respond to regulatory change, strengthen operational resilience and ensure quality remains relevant to future business needs.


 

The panel will consider:

  • Which capabilities quality organizations will need in the years ahead
  • How to turn conference insights into priorities for your organization
  • How leaders can balance compliance, innovation, resilience and performance
16:35Closing ReflectionsThe day’s key lessons will be brought together into a concise set of priorities, helping you identify the ideas most relevant to your organization and role.
16:50Event CloseThe NSF Pharmaceutical & Biotech Conference 2026 concludes.

Registration

Registration is now open. Reserve your place to join life sciences quality and regulatory professionals from across Europe for a day of practical insight, discussion and networking.

For questions about this event please contact us at [email protected]

How NSF Can Help You

Speak with NSF’s pharma biotech experts about regulatory, quality and market access challenges across global markets.

What’s New with NSF

  • NSF Hosts First External Review Panel for ‘NSF/KWTC 555’ with Key Asian Water Authorities

    August 3, 2026
    Joint standard development gains momentum to enhance confidence in Asia’s water industry and advance drinking water safety.
    Read the Story
  • NSF Achieves European Accreditation for Drinking Water Product Certification Ahead of 2027 EU Deadline

    July 22, 2026
    The ISO/IEC 17065 accreditation from BELAC complements NSF’s testing capacity, enabling end-to-end support for EU Drinking Water Directive (DWD) readiness ahead of the January 2027 deadline.
    Read the Story
  • Meet NSF at Fruit Attraction

    July 15, 2026
    NSF is excited to be exhibiting at Fruit Attraction, a leading international trade fair for the fruit and vegetable sector.
    Read the Story
  • NSF Awards World-First Community Catch Certification to Orkney Crab Fishery

    July 13, 2026
    Milestone certification sets a new benchmark for small-scale fishery sustainability and social responsibility.
    Read the Story